Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders (Q34394253)

1 August 2017

1 reference

title

Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders (English)

1 reference

1 August 2017

0 references

1 reference

8

Blennow K

1 reference

1 August 2017

6

Winblad B

1 reference

1 August 2017

1

Vanmechelen E

1 reference

1 August 2017

5

Minthon L

1 reference

1 August 2017

Vanderstichele H

2

1 reference

1 August 2017

Hulstaert F

series ordinal

3

1 reference

1 August 2017

Andreasen N

series ordinal

4

1 reference

1 August 2017

Davidsson P

series ordinal

7

1 reference

1 August 2017

publication date

1 November 2001

1 reference

Mechanisms of Ageing and Development

1 August 2017

published in

1 reference

1 August 2017

volume

122

1 reference

1 August 2017

issue

16

1 reference

1 August 2017

page(s)

2005-2011

1 reference

Amyloid Abeta40 CSF concentrations correlate to frontal lobe atrophy in frontotemporal dementia

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Cerebrospinal-fluid tau protein and aspartate aminotransferase in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Molecular classification of the dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Diagnosing dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Tau Protein in Cerebrospinal Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Cerebrospinal protein tau is elevated in early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Decreased Levels of Amyloid-beta 1-42 in Cerebrospinal Fluid of Creutzfeldt-Jakob Disease Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900304-9

7 January 2021

10.1016/S0047-6374(01)00304-9

Identifiers

DOI

1 reference

1 August 2017

1 reference